Hyundai Bioscience

048410.KQ

8.15 USD

-0.02

-0.24%

Overview

Last close

8.15 usd

Market cap

391.40M usd

52 week high

27.33 usd

52 week low

8.02 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

35.9731

Price/Book Value

12.9873

Enterprise Value

401.96M usd

EV/Revenue

37.0056

EV/EBITDA

-64.6317

Key financials

Revenue TTM

10.86M usd

Gross Profit TTM

8.24M usd

EBITDA TTM

515940.39 usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

53.80M usd

Net debt

12.98M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.